PRECIGEN, INC. Operating Cash Flow
PRECIGEN, INC. (PGEN) reported Operating Cash Flow of -$61.64 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-04
- PRECIGEN, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$17.81M.
- PRECIGEN, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$43.83M.
- PRECIGEN, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$23.46M.
- PRECIGEN, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$29.07M.
- PRECIGEN, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$87.83M.
- PRECIGEN, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$68.17M.
- PRECIGEN, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$66.93M.
- PRECIGEN, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$65.05M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$17.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$61.64M 10-Q · filed 2026-08-04 | -$85.10M derived: sum of 3 quarters · filed 2026-08-04 | -$114.17M derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2026-03-31 | -$43.83M 10-Q · filed 2026-05-13 | -$67.29M derived: sum of 2 quarters · filed 2026-05-13 | -$96.36M derived: sum of 3 quarters · filed 2026-05-13 | -$115.33M derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2025-12-31 | -$23.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$52.53M derived: sum of 2 quarters · filed 2026-03-25 | -$71.51M derived: sum of 3 quarters · filed 2026-08-04 | -$87.83M 10-K · filed 2026-03-25 | |||
| 2025-09-30 | -$29.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$48.05M derived: sum of 2 quarters · filed 2026-08-04 | -$64.37M 10-Q · filed 2025-11-13 | -$72.61M derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2025-06-30 | -$18.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$35.30M 10-Q · filed 2026-08-04 | -$43.55M derived: sum of 3 quarters · filed 2026-08-04 | -$66.28M derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2025-03-31 | -$16.32M 10-Q · filed 2026-05-13 | -$24.57M derived: sum of 2 quarters · filed 2026-05-13 | -$47.30M derived: sum of 3 quarters · filed 2026-05-13 | -$70.41M derived: sum of 4 quarters · filed 2026-05-13 | |||
| 2024-12-31 | -$8.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$30.98M derived: sum of 2 quarters · filed 2026-03-25 | -$54.08M derived: sum of 3 quarters · filed 2026-03-25 | -$68.17M 10-K · filed 2026-03-25 | |||
| 2024-09-30 | -$22.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$45.84M derived: sum of 2 quarters · filed 2025-11-13 | -$59.93M 10-Q · filed 2025-11-13 | -$75.70M derived: sum of 4 quarters · filed 2026-03-25 | |||
| 2024-06-30 | -$23.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$37.20M 10-Q · filed 2025-08-12 | -$52.96M derived: sum of 3 quarters · filed 2026-03-25 | -$69.97M derived: sum of 4 quarters · filed 2026-03-25 | |||
| 2024-03-31 | -$14.09M 10-Q · filed 2025-05-14 | -$29.86M derived: sum of 2 quarters · filed 2026-03-25 | -$46.86M derived: sum of 3 quarters · filed 2026-03-25 | -$62.63M derived: sum of 4 quarters · filed 2026-03-25 | |||
| 2023-12-31 | -$15.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$32.77M derived: sum of 2 quarters · filed 2026-03-25 | -$48.54M derived: sum of 3 quarters · filed 2026-03-25 | -$66.93M 10-K · filed 2026-03-25 | |||
| 2023-09-30 | -$17.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$32.78M derived: sum of 2 quarters · filed 2024-11-14 | -$51.16M 10-Q · filed 2024-11-14 | -$66.56M derived: sum of 4 quarters · filed 2025-03-19 | |||
| 2023-06-30 | -$15.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$34.16M 10-Q · filed 2024-08-14 | -$49.55M derived: sum of 3 quarters · filed 2025-03-19 | -$73.36M derived: sum of 4 quarters · filed 2025-03-19 | |||
| 2023-03-31 | -$18.39M 10-Q · filed 2024-05-14 | -$33.78M derived: sum of 2 quarters · filed 2025-03-19 | -$57.60M derived: sum of 3 quarters · filed 2025-03-19 | -$64.65M derived: sum of 4 quarters · filed 2025-03-19 | |||
| 2022-12-31 | -$15.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | -$39.21M derived: sum of 2 quarters · filed 2025-03-19 | -$46.26M derived: sum of 3 quarters · filed 2025-03-19 | -$65.05M 10-K · filed 2025-03-19 | |||
| 2022-09-30 | -$23.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$30.87M derived: sum of 2 quarters · filed 2023-11-09 | -$49.65M 10-Q · filed 2023-11-09 | -$64.24M derived: sum of 4 quarters · filed 2024-03-19 | |||
| 2022-06-30 | -$7.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$25.84M 10-Q · filed 2023-08-09 | -$40.42M derived: sum of 3 quarters · filed 2024-03-19 | -$57.45M derived: sum of 4 quarters · filed 2024-03-19 | |||
| 2022-03-31 | -$18.78M 10-Q · filed 2023-05-10 | -$33.37M derived: sum of 2 quarters · filed 2024-03-19 | -$50.39M derived: sum of 3 quarters · filed 2024-03-19 | -$58.17M derived: sum of 4 quarters · filed 2024-03-19 | |||
| 2021-12-31 | -$14.59M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | -$31.61M derived: sum of 2 quarters · filed 2024-03-19 | -$39.39M derived: sum of 3 quarters · filed 2024-03-19 | -$55.77M 10-K · filed 2024-03-19 | |||
| 2021-09-30 | -$17.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$24.80M derived: sum of 2 quarters · filed 2022-11-09 | -$41.18M 10-Q · filed 2022-11-09 | -$57.65M derived: sum of 4 quarters · filed 2023-03-06 | |||
| 2021-06-30 | -$7.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$24.16M 10-Q · filed 2022-08-08 | -$40.63M derived: sum of 3 quarters · filed 2023-03-06 | -$59.63M derived: sum of 4 quarters · filed 2023-03-06 | |||
| 2021-03-31 | -$16.38M 10-Q · filed 2022-05-09 | -$32.85M derived: sum of 2 quarters · filed 2023-03-06 | -$51.86M derived: sum of 3 quarters · filed 2023-03-06 | -$65.66M derived: sum of 4 quarters · filed 2023-03-06 | |||
| 2020-12-31 | -$16.47M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | -$35.47M derived: sum of 2 quarters · filed 2023-03-06 | -$49.28M derived: sum of 3 quarters · filed 2023-03-06 | -$77.02M 10-K · filed 2023-03-06 | |||
| 2020-09-30 | -$19.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$32.81M derived: sum of 2 quarters · filed 2021-11-08 | -$60.55M 10-Q · filed 2021-11-08 | -$92.69M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-06-30 | -$13.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$41.55M 10-Q · filed 2021-08-09 | -$73.69M derived: sum of 3 quarters · filed 2022-03-01 | -$100.84M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-03-31 | -$27.74M 10-Q · filed 2021-05-10 | -$59.88M derived: sum of 2 quarters · filed 2022-03-01 | -$87.03M derived: sum of 3 quarters · filed 2022-03-01 | -$120.44M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2019-12-31 | -$32.14M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$59.29M derived: sum of 2 quarters · filed 2022-03-01 | -$92.69M derived: sum of 3 quarters · filed 2022-03-01 | -$135.93M 10-K · filed 2022-03-01 | |||
| 2019-09-30 | -$27.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$60.55M derived: sum of 2 quarters · filed 2020-11-09 | -$103.78M 10-Q · filed 2020-11-09 | -$141.15M derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2019-06-30 | -$33.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$76.64M 10-Q · filed 2020-08-10 | -$114.00M derived: sum of 3 quarters · filed 2021-03-01 | -$142.82M derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2019-03-31 | -$43.23M 10-Q · filed 2020-05-11 | -$80.60M derived: sum of 2 quarters · filed 2021-03-01 | -$109.42M derived: sum of 3 quarters · filed 2021-03-01 | -$137.59M derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2018-12-31 | -$37.36M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$66.18M derived: sum of 2 quarters · filed 2021-03-01 | -$94.35M derived: sum of 3 quarters · filed 2021-03-01 | -$124.24M 10-K · filed 2021-03-01 | |||
| 2018-09-30 | -$28.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$56.99M derived: sum of 2 quarters · filed 2019-11-12 | -$86.88M 10-Q · filed 2019-11-12 | -$120.76M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2018-06-30 | -$28.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$58.06M 10-Q · filed 2019-08-09 | -$91.94M derived: sum of 3 quarters · filed 2020-03-02 | -$113.95M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2018-03-31 | -$29.89M 10-Q · filed 2019-05-09 | -$63.77M derived: sum of 2 quarters · filed 2020-03-02 | -$85.78M derived: sum of 3 quarters · filed 2020-03-02 | -$108.92M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2017-12-31 | -$33.88M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$55.89M derived: sum of 2 quarters · filed 2020-03-02 | -$79.03M derived: sum of 3 quarters · filed 2020-03-02 | -$103.72M 10-K · filed 2020-03-02 | -$104.14M 10-K · filed 2018-03-01 | ||
| 2017-09-30 | -$22.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$45.15M derived: sum of 2 quarters · filed 2018-11-08 | -$69.84M 10-Q · filed 2018-11-08 | -$70.26M 10-Q · filed 2017-11-09 | -$87.05M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-06-30 | -$23.14M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2018-08-13 | -$47.83M 10-Q · filed 2018-08-13 | -$48.25M 10-Q · filed 2017-08-09 | -$65.04M derived: sum of 3 quarters · filed 2019-03-01 | -$80.77M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-03-31 | -$24.69M 10-Q/A · filed 2018-08-13 | -$41.90M derived: sum of 2 quarters · filed 2019-03-01 | -$57.63M derived: sum of 3 quarters · filed 2019-03-01 | -$70.07M derived: sum of 4 quarters · filed 2019-03-01 | |||
| 2016-12-31 | -$17.21M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$32.94M derived: sum of 2 quarters · filed 2019-03-01 | -$45.38M derived: sum of 3 quarters · filed 2019-03-01 | -$48.99M 10-K · filed 2019-03-01 | -$55.98M 10-K · filed 2017-03-01 | ||
| 2016-09-30 | -$15.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$28.17M derived: sum of 2 quarters · filed 2017-11-09 | -$31.78M 10-Q · filed 2017-11-09 | -$19.45M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-06-30 | -$12.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$16.05M 10-Q · filed 2017-08-09 | -$3.72M derived: sum of 3 quarters · filed 2018-03-01 | $49.18M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-03-31 | -$3.61M 10-Q · filed 2017-05-10 | $8.72M derived: sum of 2 quarters · filed 2018-03-01 | $61.62M derived: sum of 3 quarters · filed 2018-03-01 | $45.10M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2015-12-31 | $12.33M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $65.23M derived: sum of 2 quarters · filed 2018-03-01 | $48.71M derived: sum of 3 quarters · filed 2018-03-01 | $35.67M 10-K · filed 2018-03-01 | |||
| 2015-09-30 | $52.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $36.38M derived: sum of 2 quarters · filed 2016-11-09 | $23.34M 10-Q · filed 2016-11-09 | $14.29M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-06-30 | -$16.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$29.56M 10-Q · filed 2016-08-09 | -$38.61M derived: sum of 3 quarters · filed 2017-03-01 | ||||
| 2015-03-31 | -$13.04M 10-Q · filed 2016-05-10 | -$22.09M derived: sum of 2 quarters · filed 2017-03-01 | |||||
| 2014-12-31 | -$9.05M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$19.86M 10-K · filed 2017-03-01 | |||||
| 2014-09-30 | -$10.81M 10-Q · filed 2015-11-09 | ||||||
| 2013-12-31 | -$10.22M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$26.07M derived: sum of 2 quarters · filed 2016-02-29 | -$53.68M 10-K · filed 2016-02-29 | ||||
| 2013-09-30 | -$15.85M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-11-07 | -$43.46M 10-Q · filed 2013-11-07 | |||||
| 2013-06-30 | -$27.61M 10-Q/A · filed 2013-10-21 | ||||||
| 2012-12-31 | -$12.33M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | -$27.61M derived: sum of 2 quarters · filed 2015-03-02 | -$61.53M 10-K · filed 2015-03-02 | ||||
| 2012-09-30 | -$15.28M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-11-07 | -$49.20M 10-Q · filed 2013-11-07 | |||||
| 2012-06-30 | -$33.92M 10-Q/A · filed 2013-10-21 | ||||||
| 2011-12-31 | -$81.76M 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |